Aprea Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Aprea Therapeutics has a total shareholder equity of $26.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $30.0M and $3.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$28.69m |
| Equity | US$26.87m |
| Total liabilities | US$3.09m |
| Total assets | US$29.96m |
Financial Position Analysis
Short Term Liabilities: APRE's short term assets ($29.6M) exceed its short term liabilities ($3.1M).
Long Term Liabilities: APRE has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: APRE is debt free.
Reducing Debt: APRE had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: APRE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: APRE has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 41.4% each year.